Año 2024 / Volumen 116 / Número 4
Original
Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?

209-215

DOI: 10.17235/reed.2023.9293/2022

Daniela Polette, Juli Busquets, Lluis Secanella Medayo, Maria Sorribas Grifell, Núria Peláez Serra, Catalina Uribe, Laura Martinez-Carnicero, Silvia Salord Vila, Fernando Guerrero, Jose Luis Vercher-Conejero, Alex Teulé, Joan Fabregat,

Resumen
Introduction: the diagnosis of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has increased significantly due to the widespread use of high-resolution imaging tests, which is why the most appropriate management at the time of diagnosis is the subject of debate, as is how to follow-up patients. Aims: the objective of this study was to analyze the frequency of imaging and endoscopic studies performed during long-term follow-up. Methods: a retrospective review was performed of a database collected between January 2008 and December 2020 of patients with an incidental diagnosis of small NF-PNETs; follow-up was closed in March 2023. The imaging tests performed at the time of diagnosis and long-term follow-up were recorded. Growing less than 1 mm per year has not been considered as a worrisome feature. Follow-up was performed through imaging tests, considering endoscopic cytology for lesions with a faster grow rate. Results: fifty-eight patients were included; the median age was 69 years. The initial mean size of the lesions studied was 12.79 mm (5-27). Follow-up was carried out only with computed tomography (CT) or magnetic resonance imaging (MRI). The initial size did not influence the behavior of the lesion in a statistically significant manner. Twenty-eight tumors (45 %) increased in size, with a growth equal to or less than 4 mm in 24 cases. The mean follow-up time was 82.41 months (12-164). No patient developed metastasis or died from PNET progression. Conclusions: the follow-up of neuroendocrine tumors of small size can be performed safely with only imaging tests.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Instrucciones para citar
Polette D, Busquets J, Secanella Medayo L, Sorribas Grifell M, Peláez Serra N, Uribe C, et all. Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?. 9293/2022


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 498 veces.
Este artículo ha sido descargado 32 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 19/10/2022

Prepublicado: 27/11/2023

Publicado: 09/04/2024

Tiempo de prepublicación: 404 días

Tiempo de edición del artículo: 538 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas